LSLaura Schwarzmann

Laura Schwarzmann

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Schwarzmann has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Arndt Hartmann

    Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

    1 shared publication
  • Christian Matek

    Institute of Pathology, Universitätsklinikum Erlangen, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg (FAU) Erlangen Germany

    1 shared publication
  • Irina Unser

    Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

    1 shared publication
  • Julius Emons

    Bavarian Cancer Research Center (BZKF), Erlangen, Germany

    1 shared publication
  • Katharina Seitz

    Bavarian Cancer Research Center (BZKF), Erlangen, Germany

    1 shared publication
  • Mareike Britt Diederich

    Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany

    1 shared publication

Latest Publications

  • Open Access

    AI-assisted histomorphological stratification of endometrial cancer: real-world validation of foundation models for molecular subtyping

    by Laura Schwarzmann, Robert Stöhr, Julius Emons, Patrik Pöschke, Katharina Seitz, Matthias Rübner, Matthias W. Beckmann, Mareike Britt Diederich, Irina Unser, Arndt Hartmann, et al.

    Endometrial cancer (EC) is classified into four molecular subtypes with distinct prognosis and treatment implications. Despite this well-established molecular classification, morpho-molecular correlations remain understudied. Artificial intelligence (AI) enables biomarker prediction from H&E-stained whole-slide images (WSIs). However, real-world validation for EC molecular subtyping is lacking. In this study, we evaluated image-based molecular subtyping in a real-world cohort derived from routine diagnostic cases with heterogeneous image quality. We benchmarked the feature extraction with the CTransPath and UNI foundation models, demonstrating robust results across different scanner hardware and quantified performance variation by additional stain normalization. UNI-based features achieved a mean AUROC of 0.646 for POLE mut ( n = 16), 0.700 for MMRd_MSI ( n = 79), 0.684 for NSMP ( n = 176), and 0.844 for p53abn ( n = 18) on external real-world data. We provided human interpretations of subtype-specific morphological features. Our findings may thus lay the foundations of a more reliable framework for personalized treatment stratification based on morphologically informed molecular subtyping.